Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p18
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 18/66)
Character Range: 49921–52938

headed "Purposes": P5915 substitute: P6026
[103] Schedule 1, Part 1, entry for Fentanyl in the form Tablet (sublingual) 800 micrograms (as citrate) [Maximum Quantity: 60; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C5904  substitute: C6027
(b) omit from the column headed "Purposes": P5904 substitute: P6027
[104] Schedule 1, Part 1, entry for Fentanyl in the form Transdermal patch 1.28 mg [Maximum Quantity: 5; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C10745 C10747 C10751 substitute: C15994 C15996 C16000
(b) omit from the column headed "Purposes": P10745 P10747 P10751 substitute: P15994 P15996 P16000
(c) omit from the column headed "Variations": V10745 V10747 V10751 substitute: V15994 V15996 V16000
[105] Schedule 1, Part 1, entry for Fentanyl in the form Transdermal patch 2.063 mg [Maximum Quantity: 5; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C10745 C10747 C10751 substitute: C15994 C15996 C16000
(b) omit from the column headed "Purposes": P10745 P10747 P10751 substitute: P15994 P15996 P16000
(c) omit from the column headed "Variations": V10745 V10747 V10751 substitute: V15994 V15996 V16000
[106] Schedule 1, Part 1, entry for Fentanyl in the form Transdermal patch 2.1 mg [Brand: APO-Fentanyl; Maximum Quantity: 5; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C10745 C10747 C10751 substitute: C15994 C15996 C16000
(b) omit from the column headed "Purposes": P10745 P10747 P10751 substitute: P15994 P15996 P16000
(c) omit from the column headed "Variations": V10745 V10747 V10751 substitute: V15994 V15996 V16000
[107] Schedule 1, Part 1, entry for Fentanyl in the form Transdermal patch 2.1 mg [Brand: Durogesic 12; Maximum Quantity: 5; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C10745 C10747 C10751 substitute: C15994 C15996 C16000
(b) omit from the column headed "Purposes": P10745 P10747 P10751 substitute: P15994 P15996 P16000
(c) omit from the column headed "Variations": V10745 V10747 V10751 substitute: V15994 V15996 V16000
[108] Schedule 1, Part 1, entry for Fentanyl in the form Transdermal patch 2.1 mg [Brand: Fentanyl Sandoz; Maximum Quantity: 5; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C10745 C10747 C10751 substitute:C15994 C15996 C16000
(b) omit from the column headed "Purposes": P10745 P10747 P10751 substitute: P15994 P15996 P16000
(c) omit from the column headed "Variations": V10745 V10747 V10751 substitute: V15994 V15996 V16000
[109] Schedule 1, Part 1, entry for Fentanyl in the form Transdermal patch 2.55 mg [Maximum Quantity: 5; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C10745 C10747 C10751 substitute: C15994 C15996 C16000
(b) omit from the column headed "Purposes": P10745 P10747 P10751 substitute: P15994 P15996 P16000
(c) omit from the column headed "Variations": V10745 V10747 V10751 substitute: V15994 V15996 V16000
[110] Schedule 1, Part 1, entry for Fentanyl in the